Quick Answer
Solid Biosciences Inc. reported Total Assets of $232.54 million for fiscal year 2025.
Solid Biosciences Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $232.54M | +23.3% |
| 2024 | $188.66M | +14.4% |
| 2023 | $164.94M | -36.6% |
| 2022 | $260.25M | +12.0% |
| 2021 | $232.38M | +35.8% |
| 2020 | $171.17M | +65.4% |
| 2019 | $103.47M | -25.9% |
| 2018 | $139.60M | +83.2% |
| 2017 | $76.19M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $273.91M | +29.3% | -11.2% |
| June 30, 2025 | $308.29M | +33.5% | -10.4% |
| March 31, 2025 | $343.90M | +38.3% | +82.3% |
| December 31, 2024 | $188.66M | +14.4% | -10.9% |
| September 30, 2024 | $211.83M | +14.7% | -8.3% |
| June 30, 2024 | $230.98M | +12.8% | -7.1% |
| March 31, 2024 | $248.69M | +8.3% | +50.8% |
| December 31, 2023 | $164.94M | -36.6% | -10.7% |
- Solid Biosciences Inc. showed an increase of +23.3% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Solid Biosciences Inc.’s total assets has grown by 205.2% (from $76.19 million to $232.54 million).
- The most recent figure is from Solid Biosciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: